Srpske NovineSrpske Novine

Colorectal Cancer Screening Cuts Death Risk by 43 Percent

A Swedish study of 376,511 people finds that taking part in colorectal cancer screening cuts the risk of dying from it by 43 percent, nearly three times higher than the program's earlier estimate.

Aleksandar Tomić3 min read0
Podeli
Laboratory image of a fecal occult blood test used for colorectal cancer screening
A fecal occult blood test detects traces of blood invisible to the naked eye, the first step in colorectal cancer screening./ Photo: Wikimedia Commons

People who actually take the test for early detection of colorectal cancer have up to a 43 percent lower risk of dying from the disease, according to a new assessment published August 20 in the journal JAMA Network Open. The study comes from a team at the Karolinska Institute and Umea University, drawing on up to 14 years of follow up on participants in Sweden’s colorectal cancer screening program in the Stockholm and Gotland region. It is the largest assessment of the program to date, and its numbers are considerably higher than those published earlier.

Stockholm and Gotland were among the first regions in Sweden to introduce regular colorectal cancer screening, back in 2008. Invitations to get tested went out over the following four years, through 2012, and researchers then tracked the fate of both invited and non-invited residents for up to 14 years afterward. Today screening is offered to everyone in Sweden between 60 and 74, every two years. The test is done at home: a kit arrives by mail, the patient collects a stool sample and sends it in for analysis, which looks for traces of blood invisible to the naked eye. If blood is found, further diagnostics follow, typically a colonoscopy.

Why is the new estimate almost three times higher than the old one?

The program’s earlier estimate put mortality among those invited at 14 percent lower than among those not invited. The new study shows the risk is 26 percent lower among everyone invited, and fully 43 percent lower among those who actually took the test. The gap comes from the fact that roughly one in three invited people never responded, which diluted the old figure with people who did not take part at all. In the new paper, titled “Fecal Occult Blood Screening Outcomes Adjusted for Contamination Bias and Nonadherence” (DOI 10.1001/jamanetworkopen.2026.29856), the authors statistically corrected for two things that had been dragging the earlier result down: some people getting tested outside the program itself, and some invitees never responding at all.

Johanes Blum, a specialist and associate professor at the Department of Clinical Science and Education at Sodersjukhuset hospital, part of the Karolinska Institute, and the study’s lead author, explains the gap between the two measurements in the institution’s statement:

“The earlier assessment of the program showed that people who received a screening invitation had a 14 percent lower risk of dying from the disease. Now we have been able to show that mortality is significantly lower among those who actually took part in the screening.”

The analysis included 376,511 people. Researchers compared those invited between 2008 and 2012 with a control group whose invitation came later or never came at all. Over the entire follow up period, 1,668 deaths from colorectal cancer were recorded. The study was funded by the Swedish Cancer Society, the Swedish Research Council and the Stockholm region, and the authors report no conflicts of interest.

Blum warns that participation still cannot be taken for granted:

“Even though screening is free and the test is simple to do, around a third of people do not send in their sample. Our study shows how important it is to take part in colorectal cancer screening, and that it really can save lives.”

The authors themselves point out the limits of the work. The results do not rest on a real time randomized comparison, but on a retrospective statistical correction meant to strip out the effect of people who were tested outside the program and those who never responded to their invitation. That kind of correction narrows the uncertainty but does not remove it, and the researchers state this explicitly as a limitation of the study. The size of the sample and the length of follow up support the reliability of the findings, and Sweden’s health registries are among the most complete in Europe, but the fact that participation in screening is associated with a lower risk of death is not the same as proof that any individual test by itself extends life. The study says nothing about possible harms of over testing, nor about the exact biological mechanism by which early detection lowers mortality, questions that further research still needs to answer.

Podeli
Komentari…
Next storyNobel Prize 2026: Medicine Monday, Peace on FridayThe first laureate is announced Monday, October 5, in Solna near Stockholm, and six announcements run through October 12. Serbia is on the same time as Stockholm.

From other sections

Most read today

  1. Greece vs Serbia: Zivkovic and Dragojevic Out in Volos
  2. Air Serbia Bars Montenegrin Fans From Larnaca Flight
  3. Student List to Elect Assembly Speaker by Majority Vote
  4. Stevandic re-elected Republika Srpska parliament speaker
  5. Guard says it targeted US radar in Bahrain

Komentari (0)

Ostavi komentar

Komentari prolaze kratku moderaciju. Lični napadi i govor mržnje se brišu.

Još nema komentara. Budi prvi i podeli mišljenje.